Results

Janssen Pharmaceuticals Inc.

10/21/2019 | Press release | Distributed by Public on 10/21/2019 17:30

Janssen Announces U.S. FDA Approval of STELARA® (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis